FDA QC实验室检查指南.docx
- 文档编号:513890
- 上传时间:2022-10-10
- 格式:DOCX
- 页数:24
- 大小:28.46KB
FDA QC实验室检查指南.docx
《FDA QC实验室检查指南.docx》由会员分享,可在线阅读,更多相关《FDA QC实验室检查指南.docx(24页珍藏版)》请在冰豆网上搜索。
FDAQC实验室检查指南
GUIDETOINSPECTIONSOFPHARMACEUTICALQUALITYCONTROLLABORATORIES
Note:
ThisdocumentisreferencematerialforinvestigatorsandotherFDA
personnel.ThedocumentdoesnotbindFDA,anddoesnoconferanyrights,
privileges,benefits,orimmunitiesfororonanyperson(s).
1.INTRODUCTION
Thepharmaceuticalqualitycontrollaboratoryservesoneofthemost
importantfunctionsinpharmaceuticalproductionandcontrol.Asignificant
portionoftheCGMPregulations(21CFR211)pertaintothequalitycontrol
laboratoryandproducttesting.Similarconceptsapplytobulkdrugs.
Thisinspectionguidesupplementsotherinspectionalinformationcontained
inotheragencyinspectionalguidancedocuments.Forexample,Compliance
Program7346.832requiringpre-approvalNDA/ANDAinspectionscontains
generalinstructionstoconductproductspecificNDA/ANDAinspectionaudits
tomeasurecompliancewiththeapplicationsandCGMPrequirements.This
includespharmaceuticallaboratoriesusedforin-processandfinished
producttesting.
2.OBJECTIVE
Thespecificobjectivewillbespelledoutpriortotheinspection.The
laboratoryinspectionmaybelimitedtospecificissues,ortheinspection
mayencompassacomprehensiveevaluationofthelaboratory'scompliancewith
CGMP's.Asaminimum,eachpharmaceuticalqualitycontrollaboratoryshould
receiveacomprehensiveGMPevaluationeachtwoyearsaspartofthe
statutoryinspectionobligation.
Ingeneraltheseinspectionsmayinclude
--thespecificmethodologywhichwillbeusedtotestanewproduct
--acompleteassessmentoflaboratory'sconformancewithGMP's
--aspecificaspectoflaboratoryoperations
3.INSPECTIONPREPARATION
FDAInspectionGuidesarebasedontheteaminspectionapproachandour
inspectionofalaboratoryisconsistentwiththisconcept.Aspartofour
efforttoachieveuniformityandconsistencyinlaboratoryinspections,we
expectthatcomplex,highlytechnicalandspecializedtestingequipment,
proceduresanddatamanipulations,aswellasscientificlaboratory
operationswillbeevaluatedbyanexperiencedlaboratoryanalystwith
specializedknowledgeinsuchmatters.
Districtmanagementmakesthefinaldecisionregardingtheassignmentof
personneltoinspections.Nevertheless,weexpectinvestigators,analysts
andotherstoworkasteamsandtoadvisemanagementwhenadditional
expertiseisrequiredtocompleteameaningfulinspection.
Teammembersparticipatinginapre-approvalinspectionmustreadandbe
familiarwithComplianceProgram7346.832,Pre-Approval
Inspections/Investigations.RelevantsectionsoftheNDAorANDAshouldbe
reviewedpriortotheinspection;butiftheapplicationisnotavailable
fromanyothersource,thisreviewwillhavetobeconductedusingthe
company'scopyoftheapplication.
Teammembersshouldmeet,ifpossible,priortotheinspectiontodiscuss
theapproachtotheinspection,todefinetherolesoftheteammembers,and
toestablishgoalsforcompletionoftheassignment.Responsibilitiesfor
developmentofallreportsshouldalsobeestablishedpriortothe
inspection.ThisincludesthepreparationoftheFDA483.
TheCenterforDrugEvaluationandResearch(CDER)mayhaveissued
deficiencyletterslistingproblemsthatthesponsormustcorrectpriorto
theapprovalofNDA/ANDA'sandsupplements.Theinspectionteamisexpected
toreviewsuchlettersonfileatthedistrictoffice,andtheyareexpected
toasktheplantforaccesstosuchletters.Theteamshouldevaluatethe
repliestotheseletterstoassurethatthedataareaccurateandauthentic.
Completetheinspectioneventhoughtherehasbeennoresponsetothese
lettersorwhentheresponseisjudgedinadequate.
4.INSPECTIONAPPROACH
A.General
InadditiontothegeneralapproachutilizedinadrugCGMPinspection,the
inspectionofalaboratoryrequirestheuseofobservationsofthe
laboratoryinoperationandoftherawlaboratorydatatoevaluate
compliancewithCGMP'sandtospecificallycarryoutthecommitmentsinan
applicationorDMF.Whenconductingacomprehensiveinspectionofa
laboratory,allaspectsofthelaboratoryoperationswillbeevaluated.
Laboratoryrecordsandlogsrepresentavitalsourceofinformationthat
allowsacompleteoverviewofthetechnicalabilityofthestaffandof
overallqualitycontrolprocedures.SOPsshouldbecompleteandadequateand
theoperationsofthelaboratoriesshouldconformtothewrittenprocedures.
Specificationsandanalyticalproceduresshouldbesuitableand,as
applicable,inconformancewithapplicationcommitmentsandcompendial
requirements.
Evaluaterawlaboratorydata,laboratoryproceduresandmethods,laboratory
equipment,includingmaintenanceandca
- 配套讲稿:
如PPT文件的首页显示word图标,表示该PPT已包含配套word讲稿。双击word图标可打开word文档。
- 特殊限制:
部分文档作品中含有的国旗、国徽等图片,仅作为作品整体效果示例展示,禁止商用。设计者仅对作品中独创性部分享有著作权。
- 关 键 词:
- FDA QC实验室检查指南 QC 实验室 检查 指南
![提示](https://static.bdocx.com/images/bang_tan.gif)